Page 12 - Visma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Time-Tested Stock Market Barometer Keeps Investors from Whipsaws in Volatile Times If you’re a buy-and-hold stock investor, you’ve tried mightily to ignore the marke...

Patients with spinal muscular atrophy (SMA) treated with a more expensive medication were found to have higher pharmacy costs but lower SMA-related health care resource utilization and medical costs compared with patients receiving standard-of-care nusinersen monotherapy.

A multivariable analysis suggested the safety and efficacy of onasemnogene abeparvovec (OA) in the treatment of older and heavier children with spinal muscular atrophy (SMA) type 1.

With the 2023 season behind us, it is once again time to rank the best of the best - the top 10 climbing performances of the year. The climbing level this season was so exceptionally high, that performances that would have cracked the Top 10 in each of the last 20 years had to be left out (they will be listed as honourable mentions). This is mostly thanks to a certain Dane, who had what might be the most dominant climbing season we have ever seen.

A retrospective, single-center study out of the Czech Republic tested the safety and efficacy of unilateral interlaminar fenestration (UILF) on the convex side in cases of SMA that also exhibit severe spinal deformities.